CD19 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD19 monoclonal antibodies for research in immunology and cell biology. CD19 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD19 is a critical surface protein expressed on B cells and plays a vital role in B cell development, activation, and signaling. It serves as a co-receptor that enhances the signaling of the B cell receptor, making it essential for effective immune responses. The study of CD19 is particularly important in understanding B cell malignancies, such as leukemia and lymphoma, as well as in the development of targeted therapies. CD19 monoclonal antibodies enable detailed investigation of B cell function and development across various experimental conditions. Researchers can utilize CD19 monoclonal antibodies to examine cellular pathways, protein interactions, and expression patterns in both normal and disease states. Santa Cruz Biotechnology monoclonal antibodies for CD19 continue to advance scientific understanding of B cell biology and immune system function, supporting breakthrough discoveries in immunology research.